Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Xinjiang Multiple Myeloma Active Trials & Centers
As of 2026-09-04, there are 5 active clinical trials for multiple myeloma hosted across 3 tertiary medical centers in Xinjiang (including The First Affiliated Hospital of Xinjiang Medical University, People's Hospital of Xinjiang Uygur Autonomous Region, Affiliated Tumor Hospital of Xinjiang Medical University).
Participating Medical Centers (3)
Active Studies in Xinjiang (5)
Population synthesized by CMDNShowing 0 published English records of 5 registry trials.
All 5 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.